You may not have been
given all your options yet

ANAVA specialises in conditions where conventional treatment has not provided adequate relief. Each patient is assessed individually, without assumptions.

Depression —
Mild & Chronic

Depression exists on a spectrum — from mild but persistent low mood that affects daily function, to chronic depression that has endured for years. Both forms can be profoundly debilitating, and both can leave patients feeling that conventional approaches haven't provided adequate relief.

Whether you've tried medication, therapy, or both — neurotherapy works through entirely different mechanisms, directly modulating the neural circuits involved in mood regulation rather than through systemic brain chemistry. This opens a new avenue for patients across the mild-to-chronic spectrum.

TMS (Transcranial Magnetic Stimulation) has FDA clearance for the treatment of depression and has been used in clinical practice for over 30 years. Response rates are meaningful — with approximately 60–68% of patients experiencing significant improvement in peer-reviewed studies.

Ask if this could help you

Relevant therapies

  • TMS — primary option for TRD
  • tDCS — adjunct support
TMS neurotherapy — primary treatment for treatment-resistant depression

~68%

Response rate in TRD with TMS, based on published meta-analyses. Individual results vary.

Person experiencing chronic pain — neurotherapy offers a new treatment pathway

"The pain that persists is not a character flaw. It is a neurological pattern."

Chronic Pain
Management

Chronic pain is not simply pain that has persisted — it represents a fundamental change in how the nervous system processes sensation. Over time, pain circuits can become sensitised, meaning the brain generates a pain experience that is no longer accurately proportional to tissue damage.

Neuromodulation targets these central sensitisation processes directly — modulating pain-processing networks in the brain rather than attempting to block peripheral pain signals. For patients who have found limited relief through analgesics, physiotherapy, or other conventional approaches, this represents a fundamentally different intervention point.

Ask if this could help you

Further conditions

03

Neurological Rehabilitation

Parkinson's disease, traumatic brain injury, and other conditions involving neurological decline may benefit from targeted neuromodulation to support function and slow progression.

Enquire

04

Anxiety Disorders

For generalised anxiety, OCD, and social anxiety that hasn't responded adequately to medication or psychological therapy, neuromodulation may offer an additional dimension of treatment.

Enquire

Not certain if ANAVA is right for you?

We'd rather you contact us with a question and find out neurotherapy isn't the right path, than spend more time uncertain. Our initial conversations are no-obligation, and our team will always give you an honest assessment.

Book ConsultationCall Us